Skip to main content

Table 1 Feature statistics of the clinical data used in the prognostic analysis

From: Improving prediction performance of colon cancer prognosis based on the integration of clinical and multi-omics data

Features

 

Statistics

Cases with Clinical and Omics Data

 

344

Gender:

Male

182 (52.9%)

Female

162 (47.1%)

Survival Status:

Alive

273 (79.4%)

Dead

71 (20.6%)

Survival Time:

Mean

779.8 (days)

Median

575.5 (days)

T Stage:

T1

10 (2.91%)

T2

62 (18.02%)

T3

254 (73.84%)

T4a

12 (3.49%)

T4b

6 (1.74%)

N Stage:

N0

211 (61.3%)

N1a

35 (10.2%)

N1b

40 (11.6%)

N2a

32 (9.3%)

N2b

26 (7.6%)

M Stage:

M0

292 (84.9%)

M1

52 (15.1%)

Age at Initial Diagnosis:

Basic Statistics (years)

Min: 31, Median: 69, Mean: 66, Max: 90

31–59

86 (25.0%)

59–69

85 (24.7%)

69–77

82 (23.8%)

77–90

91 (26.5%)